Fukangren is committed to the research and development of new drugs and the consistency evaluation of generic drugs. It has a strong team of highly educated core personnel with rich experience in new drug R&D and industrialization.
Beijing Fukangren Biopharmaceutical Technology Co., Ltd. started its drug R&D service in 1999 and is the CRO company with the longest continuous service time in China. Owns 3 pharmaceutical R&D centers, 1 clinical R&D center, 4 API production bases and 1 preparation production base